CVE-2025-29774 - Apache xml-crypto Signature Bypass Vulnerability
CVE ID : CVE-2025-29774
Published : March 14, 2025, 5:15 p.m. | 3 hours, 53 minutes ago
Description : xml-crypto is an XML digital signature and encryption library for Node.js. An attacker may be able to exploit a vulnerability in versions prior to 6.0.1, 3.2.1, and 2.1.6 to bypass authentication or authorization mechanisms in systems that rely on xml-crypto for verifying signed XML documents. The vulnerability allows an attacker to modify a valid signed XML message in a way that still passes signature verification checks. For example, it could be used to alter critical identity or access control attributes, enabling an attacker with a valid account to escalate privileges or impersonate another user. Users of versions 6.0.0 and prior should upgrade to version 6.0.1 to receive a fix. Those who are still using v2.x or v3.x should upgrade to patched versions 2.1.6 or 3.2.1, respectively.
Severity: 0.0 | NA
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
Published : March 14, 2025, 5:15 p.m. | 3 hours, 53 minutes ago
Description : xml-crypto is an XML digital signature and encryption library for Node.js. An attacker may be able to exploit a vulnerability in versions prior to 6.0.1, 3.2.1, and 2.1.6 to bypass authentication or authorization mechanisms in systems that rely on xml-crypto for verifying signed XML documents. The vulnerability allows an attacker to modify a valid signed XML message in a way that still passes signature verification checks. For example, it could be used to alter critical identity or access control attributes, enabling an attacker with a valid account to escalate privileges or impersonate another user. Users of versions 6.0.0 and prior should upgrade to version 6.0.1 to receive a fix. Those who are still using v2.x or v3.x should upgrade to patched versions 2.1.6 or 3.2.1, respectively.
Severity: 0.0 | NA
Visit the link for more details, such as CVSS details, affected products, timeline, and more...